Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760) Stock Analysis

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

3.63 M

Shareholding (Mar 2025)

FII

0.01%

Held by 2 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

With a fall in Net Sales of -23.8%, the company declared Very Negative results in Mar 25

The company has declared negative results for the last 3 consecutive quarters
INTEREST(HY) At CNY 10.2 MM has Grown at 18.05%
OPERATING CASH FLOW(Y) Lowest at CNY 11,068.95 MM
NET PROFIT(HY) At CNY 3,660.85 MM has Grown at -23.38%

With ROE of 24.07%, it has a expensive valuation with a 7.25 Price to Book Value

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 283,105 Million (Large Cap)

P/E

30.00

Industry P/E

Dividend Yield

2.11%

Debt Equity

-0.43

Return on Equity

24.07%

Price to Book

7.25

Revenue and Profits:

Net Sales:

8,410 Million

(Quarterly Results - Jun 2025)

Net Profit:

2,540 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-16.25%

6 Months

-14.05%

1 Year

-23.29%

2 Years

-31.06%

3 Years

-39.02%

4 Years

-43.34%

5 Years

-42.03%

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

11.71%

EBIT Growth (5y)

9.81%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.46

Sales to Capital Employed (avg)

0.95

Tax Ratio

9.95%

Dividend Payout Ratio

65.07%

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

76.50%

ROE (avg)

29.93%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

7.25

EV to EBIT

28.76

EV to EBITDA

24.31

EV to Capital Employed

12.05

EV to Sales

8.17

PEG Ratio

Dividend Yield

2.11%

ROCE (Latest)

41.92%

ROE (Latest)

24.07%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -23.80% vs 10.24% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -42.45% vs 14.03% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,409.50",
          "val2": "11,036.40",
          "chgp": "-23.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,997.80",
          "val2": "4,891.10",
          "chgp": "-38.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.30",
          "val2": "4.70",
          "chgp": "12.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.30",
          "val2": "0.30",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,540.10",
          "val2": "4,414.10",
          "chgp": "-42.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "305.20%",
          "val2": "412.80%",
          "chgp": "-10.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 5.09% vs 15.15% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 1.40% vs 20.47% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "36,325.20",
          "val2": "34,565.80",
          "chgp": "5.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "13,875.40",
          "val2": "13,300.60",
          "chgp": "4.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "106.20",
          "val2": "85.90",
          "chgp": "23.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "77.50",
          "val2": "-220.60",
          "chgp": "135.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11,740.00",
          "val2": "11,578.40",
          "chgp": "1.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "340.60%",
          "val2": "354.70%",
          "chgp": "-1.41%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

8,409.50

11,036.40

-23.80%

Operating Profit (PBDIT) excl Other Income

2,997.80

4,891.10

-38.71%

Interest

5.30

4.70

12.77%

Exceptional Items

0.30

Consolidate Net Profit

2,540.10

4,414.10

-42.45%

Operating Profit Margin (Excl OI)

305.20%

412.80%

-10.76%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is -23.80% vs 10.24% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -42.45% vs 14.03% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

36,325.20

34,565.80

5.09%

Operating Profit (PBDIT) excl Other Income

13,875.40

13,300.60

4.32%

Interest

106.20

85.90

23.63%

Exceptional Items

77.50

-220.60

135.13%

Consolidate Net Profit

11,740.00

11,578.40

1.40%

Operating Profit Margin (Excl OI)

340.60%

354.70%

-1.41%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 5.09% vs 15.15% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 1.40% vs 20.47% in Dec 2023

All Annual Results

Company CV

About Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available